Thriving after hematopoietic stem cell transplant: A focus on positive changes in quality of life

Expert Review of Pharmacoeconomics and Outcomes Research

Volumn 4, Issue 1, 2004, Pages 111-123

  Bishop, Michelle M ^a   Wingard, John R ^b  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

Cancer; Hematopoietic stem cell transplant; Late effects; Positive outcomes; Quality of life; Resilience; Thriving

Indexed keywords

AVASCULAR NECROSIS; COGNITIVE DEFECT; DISEASE CONTROL; ENDOCRINE DISEASE; EYE DISEASE; GRAFT VERSUS HOST REACTION; HEMATOLOGIC DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNE DEFICIENCY; LUNG DISEASE; MALIGNANT NEOPLASTIC DISEASE; OUTCOMES RESEARCH; PRACTICE GUIDELINE; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; RECURRENT INFECTION; REVIEW; SURVIVAL RATE; WELLBEING;

EID: 1142275184     PISSN: 14737167     EISSN: None     Source Type: Journal    
DOI: 10.1586/14737167.4.1.111     Document Type: Review

References (119)

1. Appelbaum FR. The use of bone marrow and peripheral blood stem cell transplantation in the treatment of cancer. CA Cancer J. Clin. 46, 142-164 (1996).
2. Kessinger A, Armitage JO. The use of peripheral stem cell support of high-dose chemotherapy. Important Adv. Oncol. 167-175 (1993).
3. Bortin MM, Horowitz MM, Gale RP et al. Changing trends in allogeneic bone marrow transplantation for leukemia in the 1980s. JAMA 268(5), 607-612 (1992).
4. Sobocinski KA, Horowitz MM, Rowlings PA et al. Bone marrow transplantation-1994: a report from the International Bone Marrow Transplant Registry and the North American Autologous Bone Marrow Transplant Registry. J. Hematother. 3(2), 95-102 (1994).
5. Storb R, Longton G, Anasetti C et al. Changing trends in marrow transplantation for aplastic anemia. Bone Marrow Transplant 10, 45-52 (1992).
6. Zittoun RA, Mandell F, Willemze R. Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. N. Engl. J. Med. 332(4), 217-223 (1995).
7. Thomas ED, Clift RA, Fefer A et al. Marrow transplantation for the treatment of chronic myelogenous leukemia. Ann. Intern. Med. 104(2), 155-163 (1986).
8. Attal M, Harousseau JL, Stoppa AM et al. A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Francais du Myelome. N. Engl. J. Med. 335(2), 91-97 (1996).
9. Gahrton G, Tura S, Ljungman P et al. Allogeneic bone marrow transplantation in multiple myeloma. European Group for Bone Marrow Transplantation. N. Engl. J. Med. 325(18), 1267-1273 (1991).
10. Linch DC, Winfield D, Goldstone AH et al. Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin's disease: results of a BNLI randomised trial. Lancet 341(8852), 1051-1054 (1993).
11. Philip T, Guglielmi C, Hagenbeek A et al. Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma. N. Engl. J. Med. 333(23), 1540-1545 (1995).
12. Schouten HC, Qian W, Kvaloy S et al. High-dose therapy improves progression-free survival and survival in relapsed follicular non-Hodgkin's lymphoma: results from the randomized European CUP trial. J. Clin. Oncol. 21(21), 3918-3927 (2003).
13. Kolb HJ, Bender-Gotze C. Late complications after allogeneic bone marrow transplantation for leukaemia. Bone Marrow Tansplant 6(2), 61-72 (1990).
14. Deeg HJ. Delayed complications and long-term effects after bone marrow transplantation. Hematol. Oncol. Clin. North Am. 4(3), 641-657 (1990).
15. Sullivan KM, Mori M, Sanders J et al. Late complications of allogeneic and autologous marrow transplantation. Bone Marrow Tansplant 10(Suppl.) 1127-1134 (1992).
16. Duell T, Van Lint MT, Ljungman P et al. Health and functional status of long-term survivors of bone marrow transplantation. EBMT Working Party on Late Effects and EULEP Study Group on Late Effects. European Group for Blood and Marrow Transplantation. Ann. Intern. Med. 126(3), 184-192 (1997).
17. Wingard JR, Santos GW, Saral R. Late-onset interstitial pneumonia following allogeneic bone marrow transplantation. Transplantation 39(1), 21-23 (1985).
18. Raschko JW, Cottler-Fox M, Abbondanzo SL, Torrisi JR, Spitzer TR, Deeg HJ. Pulmonary fibrosis after bone marrow transplantation responsive to treatment with prednisone and cyclosporin. Bone Marrow Transplant 4(2), 201-205 (1989).
19. Prince DS, Wingard JR, Saral R, Santos GW, Wise RA. Longitudinal changes in pulmonary function following bone marrow transplantation. Chest 96(2), 301-306 (1989).
20. Springmeyer SC, Silvestri RC, Flournoy N et al. Pulmonary function of marrow transplant patients. I. Effects of marrow infusion, acute graft versus host disease and interstitial pneumonitis. Exp. Hematol. 12(10), 805-810 (1984).
21. Holland HK, Wingard JR, Beschorner WE, Saral R, Santos GW. Bronchiolitis obliterans in bone marrow transplantation and its relationship to chronic graft-v-host disease and low serum IgG. Blood 72(2), 621-627 (1988).
22. Clark JG, Crawford SW, Madtes DK, Sullivan KM. Obstructive lung disease after allogeneic marrow transplantation. Clinical presentation and course. Ann. Intern. Med. 111(5), 368-376 (1989).
23. Deeg HJ, Flournoy N, Sullivan KM et al. Cataracts after total body irradiation and marrow transplantation: a sparing effect of dose fractionation. Int. J. Radiat. Oncol. Biol. Phys. 10(7), 957-964 (1984).
24. Jabs DA, Wingard J, Green WR, Farmer ER, Vogelsang G, Saral R. The eye in bone marrow transplantation. III. Conjunctival graft versus host disease. Arch Ophthalmol. 107(9), 1343-1348 (1989).
25. Dunn JP, Jabs DA, Wingard J, Enger C, Vogelsang G, Santos G. Bone marrow transplantation and cataract development. Arch Ophthalmol. 111(10), 1367-1373 (1993).
26. Socie G, Selimi F, Sedel L et al. Avascular necrosis of bone after allogeneic bone marrow transplantation: clinical findings, incidence and risk factors. Br. J. Haematol. 86(3), 624-628 (1994).
27. Socie G, Cahn JY, Carmelo J et al. Avascular necrosis of bone after allogeneic bone marrow transplantation: analysis of risk factors for 4388 patients by the Societe Francaise de Greffe de Moelle (SFGM). Br. J. Haematol. 97(4), 865-870 (1997).
28. Wingard JR, Plotnick LP, Freemer CS et al. Growth in children after bone marrow transplantation: busulfan plus cyclophosphamide versus cyclophosphamide plus total body irradiation. Blood 79(4), 1068-1073 (1992).
29. Sanders JE, Buckner CD, Amos D et al. Ovarian function following marrow transplantation for aplastic anemia or leukemia. J. Clin. Oncol. 6(5), 813-818 (1988).
30. Andrykowski MA, Brady MJ, Greiner CB et al. 'Returning to normal' following bone marrow transplantation: outcomes, expectations and informed consent. Bone Marrow Transplant 15(4), 573-581 (1995).
31. Baruch J, Benjamin S, Treleaven J, Wilcox AH, Barron JL, Powles R. Male sexual function following bone marrow transplantation. Bone Marrow Transplant 7(Suppl. 2), 52 (1991).
32. Andrykowski MA, Altmaier EM, Barnett RL, Burish TG, Gingrich R, Henslee-Downey PJ. Cognitive dysfunction in adult survivors of allogeneic marrow transplantation: relationship to dose of total body irradiation. Bone Marrow Trans 6(4), 269-276 (1990).
33. Kramer JH, Crittenden MR, DeSantes K, Cowan MJ. Cognitive and adaptive behavior 1 and 3 years following bone marrow transplantation. Bone Marrow Transplant 19(6), 607-613 (1997).
34. Smedler AC, Ringden K, Bergman H, Bolme P. Sensory-motor and cognitive functioning in children who have undergone bone marrow transplantation. Acta Paediatr. Scand. 79(6-7), 613-621 (1990).
35. Parth P, Dunlap WP, Kennedy RS, Ordy JM, Lane NE. Motor and cognitive testing of bone marrow transplant patients after chemoradiotherapy. Percept. Mot. Skills 68(3 Pt 2), 1227-1241 (1989).
36. Sullivan KM, Agura E, Anasetti C et al. Chronic graft versus host disease and other late complications of bone marrow transplantation. Semin. Hematol. 28(3), 250-259 (1991).
37. Wingard JR, Piantadosi S, Vogelsang GB et al. Predictors of death from chronic graft versus host disease after bone marrow transplantation. Blood 74(4), 1428-1435 (1989).
38. Atkinson K, Farewell V, Storb R et al Analysis of late infections after human bone marrow transplantation: role of genotypic nonidentity between marrow donor and recipient and of nonspecific suppressor cells in patients with chronic graft versus host disease. Blood 60(3), 714-720 (1982).
39. Ochs L, Shu XO, Miller J et al. Late infections after allogeneic bone marrow transplantations: comparison of incidence in related and unrelated donor transplant recipients. Blood 86(10), 3979-3986 (1995).
40. Socie G, Stone J, Sobocinski KA, Gluckman E, Horowitz MM. Analysis of late causes of death among long-term survivors after allogeneic bone marrow transplantation. Exp. Hematol. 25(8), 779 (1997).
41. Socie G, Henry-Amar M, Cosset JM, Devergie A, Girinsky T, Gluckman E. Increased incidence of solid malignant tumors after bone marrow transplantation for severe aplastic anemia. Blood 78(2), 277-279 (1991).
42. Socie G, Kolb HJ, Ljungman P. Malignant diseases after allogeneic bone marrow transplantation: the case for assessment of risk factors. Br. J. Haematol. 80(4), 427-430 (1992).
43. Witherspoon RP, Fisher LD, Schoch G et al. Secondary cancers after bone marrow transplantation for leukemia or aplastic anemia. N. Engl. J. Med. 321(12), 784-789 (1989).
44. Curtis RE, Rowlings PA, Deeg HJ et al. Solid cancers after bone marrow transplantation. N. Engl. J. Med. 336(13), 897-904 (1997).
45. Goldman JM, Gale RP, Horowitz MM et al. Bone marrow transplantation for chronic myelogenous leukemia in chronic phase. Increased risk for relapse associated with T-cell depletion. Ann. Intern. Med. 108(6), 806-814 (1988).
46. Barrett AJ, Horowitz MM, Gale RP et al. Marrow transplantation for acute lymphoblastic leukemia: factors affecting relapse and survival. Blood 74(2), 862-871 (1989).
47. Doney K, Fisher LD, Appelbaum FR et al. Treatment of adult acute lymphoblastic leukemia with allogeneic bone marrow transplantation. Multivariate analysis of factors affecting acute graft versus host disease, relapse and relapse-free survival. Bone Marrow Transplant 7(6), 453-459 (1991).
48. Socie G, Devergie A, Girinsky T et al. Influence of the fractionation of total body irradiation on complications and relapse rate for chronic myelogenous leukemia. The Groupe d'Etude des greffes de moelle osseuse (GEGMO). Int. J. Radiat. Oncol. Biol. Phys. 20(3), 397-404 (1991).
49. Andrykowski MA, Greiner CB, Altmaier EM et al. Quality of life following bone marrow transplantation: findings from a multicentre study. Br. J. Cancer. 71(6), 1322-1329 (1995).
50. Andrykowski MA, Bruehl S, Brady MJ, Henslee-Downey PJ. Physical and psychosocial status of adults one-year after bone marrow transplantation: a prospective study. Bone Marrow Transplant 15(6), 837-844 (1995).
51. Baker F, Wingard JR, Curbow B et al. Quality of life of bone marrow transplant long-term survivors. Bone Marrow Transplant 13(5), 589-596 (1994).
52. Bush NE, Haberman M, Donaldson G, Sullivan KM. Quality of life of 125 adults surviving 6-18 years after bone marrow transplantation. Soc. Sci. Med. 40(4), 479-490 (1995).
53. Baker F, Curbow B, Wingard JR. Role retention and quality of life of bone marrow transplant survivors. Soc. Sci. Med. 32(6), 697-704 (1991).
54. Chao NJ, Tierney DK, Bloom JR et al. Dynamic assessment of quality of life after autologous bone marrrow transplantation. Blood 80(3), 825-830 (1992).
55. Schmidt GM, Niland JC, Forman SJ et al. Extended follow-up in 212 long-term allogeneic bone marrow transplant survivors. Transplantation 55(3), 551-557 (1993).
56. Wingard JR, Curbow B, Baker F, Piantadosi S. Health, functional status and employment of adult survivors of bone marrow transplantation. Ann. Intern. Med. 114(2), 113-118 (1991).
57. Wingard JR, Curbow B, Baker F, Zabora J, Piantadosi S. Sexual satisfaction in survivors of bone marrow transplantation. Bone Marrow Transplant 9(3), 185-190 (1992).
58. Zittoun R, Suciu S, Watson M et al. Quality of life in patients with acute myelogenous leukemia in prolonged first complete remission after bone marrow transplantation (allogeneic or autologous) or chemotherapy: a cross-sectional study of the EORTC-GIMEMA AML 8A trial. Bone Marrow Transplant 20(4), 307-315 (1997).
59. Sutherland HJ, Fyles GM, Adams G et al. Quality of life following bone marrow transplantation: a comparison of patients reports with population norms. Bone Marrow Transplant 19, 1129-1136 (1997).
60. Molassiotis A, van den Akker O, Milligan DW et al. Quality of life in long-term survivors of marrow transplantation: Comparison with a matched group receiving maintenance chemotherapy. Bone Marrow Transplant 17, 249-258 (1996).
61. Chiodi S, Spinelli SRG, Petti AR et al. Quality of life in 244 recipients of allogenic bone marrow transplantation. Br. J. Haematol. 110, 614-619 (2000).
62. Worel N, Biener D, Kalhs P et al. Long-term outcome and quality of life of patients who are alive and in complete remission more than two years after allogeneic and syngeneic stem cell transplantation. Bone Marrow Transplant 30(9), 619-626 (2002).
63. Molassiotis A, Van Den Akker OB, Boughton BJ. Perceived social support, family environment and psychosocial recovery in bone marrow transplant long-term survivors. Soc. Sci. Med. 44(3), 317-325 (1997).
64. Heinonen H, Volin L, Uutela A, Zevon M, Barrick C, Ruutu T. Quality of life and factors related to perceived satisfaction with quality of life after allogeneic bone marrow transplantation. Ann. Hematol. 80(3), 137-143 (2001).
65. Syrjala KL, Chapko MK, Vitaliano PP, Cummings C, Sullivan KM. Recovery after allogeneic marrow transplantation: prospective study of predictors of long-term physical and psychosocial functioning. Bone Marrow Transplant 11, 319-327 (1993).
66. Broers A, Kaptein AA, Cessie SL, Fibbe W, Hengeveld MW. Psychological functioning and quality of life following bone marrow tranplantation: a 3-year follow-up study. J. Psych. Res. 45, 11-21 (2000).
67. Fife BL, Huster GA, Cornetta KG, Kennedy VN, Akard LP, Broun ER. Longitudinal study of adaptation to the stress of bone marrow transplantation. J. Clin. Oncol. 18(7), 1539-1549 (2000).
68. Andrykowski MA, Henslee PJ, Farrall MG. Physical and psychosocial functioning of adult survivors of allogeneic bone marrow transplantation. Bone Marrow Transplant 4(1), 75-81 (1989).
69. Andrykowski MA, Henslee PJ, Barnett RL. Longitudinal assessment of psychosocial functioning of adult survivors of allogeneic bone marrow transplantation. Bone Marrow Tansplant 4(5), 505-509 (1989).
70. Cordova MJ, Cunningham LL, Carlson CR, Andrykowski MA. Post-traumatic growth following breast cancer: a controlled comparison study. Health Psychol 20(3), 176-185 (2001).
71. Cohen LH, Cimbolic K, Armeli SR, Hettler TR. Quantitative Assessment of Thriving. J. Soc. Issues 54(2), 323-335 (1998).
72. Carver CS. Resilience and thriving: Issues, Models and Linkages. J. Soc. Issues 54(2), 245-266 (1998).
73. O'Leary VE, Ickovics JR. Resilience and thriving in response to challenge: an opportunity for a paradigm shift in women's health. Women's Health: Res. Gender, Behav. Pol. 1(2), 121-142 (1995).
74. Hengeveld MW, Houtman RB, Zwaan FE. Psychological aspects of bone marrow transplantation: a retrospective study of 17 long-term survivors. Bone Marrow Transplant 3(1), 69-75 (1988).
75. Ferrell B, Grant M, Schmidt GM et al. The meaning of quality of life for bone marrow transplant survivors. Part 2. Improving quality of life for bone marrow transplant survivors. Cancer Nurs. 15(4), 247-253 (1992).
76. Ferrell B, Grant M, Schmidt GM et al. The meaning of quality of life for bone marrow transplant survivors. Part I. The impact of bone marrow transplantation on quality of life. Cancer Nurs. 15, 153-160 (1992).
77. Belec RH. Quality of life: Perceptions of long-term survivors of bone marrow transplantation. Oncol. Nurs. Forum. 19(1), 31-37 (1992).
78. Curbow B, Legro MW, Baker F, Wingard JR. Loss and recovery themes of long-term survivors of bone marrow transplants. J. Psychosoc. Oncol. 10(4), 1-20 (1993).
79. Curbow B, Somerfield MR, Baker F, Wingard JR, Legro MW. Personal changes, dispositional optimism and psychological adjustment to bone marrow transplantation. J. Behav. Med. 16(5), 423-443 (1993).
80. Andrykowski MA, Brady MJ, Hunt JW. Positive psychosocial adjustment in potential bone marrow transplant recipients: cancer as a psychosocial transition. Psychooncology 2, 261-276 (1993).
81. Ross RD, Stockdale FE, Jacobs C. Cancer Patient Behavior Scale: scores of cancer patients and healthy adults. Proc. Am. Soc. Clin. Oncol. 19, 348 (1978).
82. Fromm K, Andrykowski MA, Hunt J. Positive and negative psychosocial sequelae of bone marrow transplantation: Implications for quality of life assessment. J. Behav. Med. 19(3), 221-240 (1996).
83. Tedeschi RG, Calhoun LG. The Post-traumatic Growth Inventory: measuring the positive legacy of trauma. J. Trauma Stress. 9(3), 455-471 (1996).
84. Bishop MM, Brady MJ, Beaumont JL et al. Post-traumatic growth: a late effect of stem cell transplantation. Biol. Blood Marrow Trans. 9(2), 70 (2003).
85. Sears SR, Stanton AL, Danoff-Burg S. The yellow brick road and the emerald city: benefit finding, positive reappraisal coping and post-traumatic growth in women with early-stage breast cancer. Health Psychol. 22(5), 487-497 (2003).
86. Cruess DG, Antoni MH, McGregor BA et al. Cognitive-behavioral stress management reduces serum cortisol by enhancing benefit finding among women being treated for early stage breast cancer. Psychosom. Med. 62(3), 304-308 (2000).
87. Antoni MH, Lehman JM, Kilbourn KM et al. Cognitive-behavioral stress management intervention decreases the prevalence of depression and enhances benefit finding among women under treatment for early-stage breast cancer. Health Psychol. 20, 20-32 (2001).
88. Lee SJ, Bishop MM, Odom LC et al. Preventive health behaviors of stem cell transplant survivors. Blood 98(11), 403-403 (2003).
89. Mallaghan M, Pemberton J. Some behavioural changes in 493 patients after an acute myocardial infarction. Br. J. Prev. Soc Med. 31(2), 86-90 (1977).
90. Epel ES, McEwen BS, Ickovics JR. Embodying psychological thriving: physical thriving in response to stress. J. Soc. Iss. 54(2), 301-322 (1998).
91. Parkes CM. Psycho-social transitions: a field for study. Soc. Sci. Med. 5, 101-115 (1971).
92. Frankl VE. Man's Search for Meaning: Introduction to Logotherapy. Beacon Press, Boston, MA, USA (1962).
93. Yalom I. Existential Psychotherapy. Random House, NY, USA (1980).
94. Horowitz MJ. Stress Response Syndromes. Second Edition. Aronson, Northvale, NJ, USA (1986).
95. Janoff-Bulman R. The aftermath of victimization: Rebuilding shattered assumptions. In: Trauma and Its Wake. Figley CR (Ed.). Brunner/Mazel, NY, USA, 15-33 (1985).
96. Mohamed NE, Förster C. Finding meaning and adjustment to cancer: a longitudinal study. Paper presented at the 17th European Health Psychology Society Congress. Kos, Greece (2003).
97. Taylor SE. Adjustment to threatening events: a theory of cognitive adaptation. Am. Psychol. 38(11), 1161-1173 (1983).
98. Calhoun LG, Tedeschi RG. Posttraumatic growth: the positive lessons of loss. In: Meaning Reconstruction and the Experience of Loss. RA Neimeyer (Ed.). The American Psychological Association, Washington DC, USA, 157-172 (2001)
99. Horowitz MJ. Stress, states and person schemas. Psychological Inq. 1(1), 25-26 (1990).
100. Janoff-Bulman R. Shattered Assumptions: Towards a New Psychology of Trauma. Free Press (1992).
101. Tennen H, Affleck G. Benefit-finding and benefit-reminding. In: Handbook of Positive Psychology. Snyder CR, Lopez SJ (Eds). Oxford University Press, London, UK, 584-597 (2002).
102. Park CL, Cohen LH, Murch RL. Assessment and prediction of stress-related growth. J. Pers. 64(1), 71-105 (1996).
103. Cohen SR, Mount BM, Tomas JJN, Mount LF. Existential well-being is an important determinant of quality of life: evidence from the McGill quality of life questionnaire. Cancer 77(3), 576-586 (1996).
104. Molassiotis A, Morris PJ. The meaning of quality of life and the effects of unrelated donor bone marrow transplants for chronic myeloid leukemia in adult long-term survivors. Cancer Nurs. 21(3), 205-211 (1998).
105. Whedon M, Ferrell BR. Quality of life in adult bone marrow transplant patients: beyond the first year. Sem. Oncology Nurs. 10(1), 42-57 (1994).
106. Tschuschke V, Pfleiderer K, Denzinger R, Hertenstein B, Kachele H, Arnold R. Coping with bone marrow transplantation. A contribution to adaptive vs. maladaptive coping. Psychother. Psychosom. Med. Psychol. 44(9-10), 346-354 (1994).
107. Neuser J. Personality and survival time after bone marrow transplantation. J. Psychosom. Res. 32(4-5), 451-455 (1988).
108. Andrykowski MA, Brady MJ, Henslee-Downey PJ. Psychosocial factors predictive of survival after allogeneic bone marrow transplantation for leukemia. Psychosom. Med. 56, 432-439 (1994).
109. Molassiotis A, van den Akker O, Milligan DW, Goldman JM. Symptom distress, coping style and biological variables as predictors of survival after bone marrow transplantation. J. Psychosomat. Res. 42(3), 275-285 (1997).
110. Broers S, Hengeveld MW, Kaptein AA, Le Cessie S, van de Loos F, de Vriess T. Are pretransplant psychological variables related to survival after bone marrow transplantation? A prospective study of 123 consecutive patients. J. Psychosomt. Res. 45(4), 341-351 (1998).
111. Sullivan AK, Szkrumelak N, Hoffman LH. Psychological risk factors and early complications after bone marrow transplantation in adults. Bone Marrow Transplant 24(10), 1109-1120 (1999).
112. Loberiza FR Jr, Rizzo JD, Bredeson CN et al. Association of depressive syndrome and early deaths among patients after stem-cell transplantation for malignant diseases. J. Clin. Oncol. 20(8), 2118-2126 (2002).
113. Murphy KC, Jenkins PL, Whittaker JA. Psychosocial morbidity and survival in adult bone marrow transplant recipients - a follow-up study. Bone Marrow Transplant 18199-201 (1996).
114. Seligman ME, Csikszentmihalyi M. Positive psychology: an introduction. Am. Psychol. 55(1), 5-14 (2000).
115. Special issue: thriving: broadening the paradigm beyond illness to health. J. Soc Issues. 54(2), (1998).
116. Calhoun LG, Tedeschi RG. The foundations of posttraumatic growth: new perspectives. Psychological Inq. (2003) (In Press).
117. Calhoun LG, Tedeschi RG. Facilitating Post-traumatic Growth: a Clinician's Guide. Lawrence Erlbaum Associates, Mahwah, NJ, USA (1999).
118. Johnson Vickberg SM, DuHamel KN, Smith MY et al. Global meaning and psychological adjustment among survivors of bone marrow transplantation. Psychooncology 10, 29-39 (2001).
119. Xuereb MC, Dunlop R. The Experience of leukemia and bone marrow transplant: searching for meaning and agency. Psychooncology 12, 397-409 (2003).